Erratum to "Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome".
Cesar Daniel Alonso-BelloMaría Del Carmen Jiménez-MartínezMaría Eugenia Vargas-CamañoSagrario Hierro-OrozcoMario Alberto Ynga-DurandLaura Berrón-RuizJulio César Alcántara-MontielLeopoldo Santos-ArgumedoDiana Andrea Herrera-SánchezFernando Lozano-PatiñoMaría Isabel Castrejón-VázquezPublished in: Case reports in immunology (2021)
[This corrects the article DOI: 10.1155/2019/6357256.].